Attendees interested in learning more about CoSara products, including the TB and HPV tests on the Company's upcoming Co-Dx PCR platform, are encouraged to stop by at VIROCON 2025. CoSara will be ...

It’s a move that could alter care for millions of women and significantly affect those across the Brazos Valley, especially ...

The test, which will use Iso-PAS technology, will be developed by Nipro of Japan in collaboration with other companies, institutes, and nonprofit organizations.

REVEAL GENOMICS, S.L., a Barcelona-based biotechnology company focused on advancing precision oncology through biomarker innovation, announced today the presentation of seven studies at the upcoming ...

A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort ...

The head of HSE Bernard Gloster issued an 'unequivocal' apology yesterday to a couple who agreed to ending her pregnancy ...

At the meeting, researchers shared real-world data showing ctDNA positivity at the end of treatment was prognostic across lymphoma subtypes and better than PET scans.